Interesting to read that percutaneous coronary intervention did not confer any survival benefit (nor protection from myocardial infarction) in an international randomized controlled trial of 888 patients when compared to medical therapy!
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Myocardial Infarction
July 6, 2018
A detailed and somewhat disheartening analysis of stem cell therapy for cardiac failure.
March 5, 2018
A few months after its publication, the ORBITA trial results do not seem to have filtered adequately to cardiac multidisciplinary teams worldwide.
February 28, 2018
A retrospective Mount Sinai small series on selective emergent implantation of long-term ventricular assist devices in cardiogenic shock. It challenges the traditional concept of short-term stabilisation with ECMO or short-term support, and is likely to generate criticism and discussions.
November 15, 2017
With the impressive average of 150 mitral repairs annually for the last 16 years (possibly a world record, even more impressive given the population of Portugal), the Coimbra team led by Antunes reflects on six cases of circumflex artery injury, mostly in non-right dominant anatomy as expected.
November 7, 2017
This video demonstrates how the author teaches a cardiac surgical resident to do a repair of a postinfarction ventricular septal defect.
July 26, 2017
This collaborative position paper recommendations are provided on the management of peri-operative myocardial infarction in patients undergoing CABG.
These recommendations are based on thorough literature review and are illustrated in a practical flowchart.
July 7, 2017
Patient Care
A boy’s growth had fallen well behind that of his twin brother, leading doctors in Abu Dhabi, UAE, to discover and surgically treat a congenital heart condition.
June 22, 2017
The Amsterdam Investigator-initiated Absorb Strategy All-comers Trial report safety concerns identified in early results for the bioresorbable scaffold drug eluting stent. The scaffold group experienced significantly higher rates of device thrombosis than the stent group (3.5% vs 0.9%; p<0.001).
February 17, 2017
These authors from Spain retrospectively analyzed a group of 805 patients undergoing isolated heart valve surgery in order to correlate levels of high-sensitivity troponin T (hs-cTnT) and CK-MB with whether a patient experienced a postoperative MI, as diagnosed by EKG and/or TTE.